Effects of H1 antihistamines on adhesion molecules: A possible rationale for long-term treatment

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages 49-53

  Ciprandi, G ^a   Passalacqua, G ^a   Canonica, G W ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cell adhesion; Cellular activation; ICAM 1; Soluble mediators

Indexed keywords

AZELASTINE; CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; LEVOCABASTINE; LORATADINE; OXATOMIDE; TERFENADINE; CELL ADHESION MOLECULE;

ALLERGIC REACTION; ARTICLE; CELL ACTIVATION; DRUG ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; ANIMAL; CLASSIFICATION; EPITHELIUM; PHYSIOLOGY; REVIEW;

ANIMALS; CELL ADHESION MOLECULES; EPITHELIUM; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1;

EID: 0032777030     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00011.x-i1     Document Type: Article

References (30)

1. Springer T. Adhesion receptors of the immune system. Nature 1990; 346:425-33.
2. Canonica GW, Ciprandi G, Pesce GP, et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Archs Allergy Clin Immunol 1995; 107:99.
3. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts G, Rothlein R. Intercellular adhesion molecule 1 in the pathogenesis of asthma. Science 1990; 247:456-60.
4. Gundel RH, Wegner CD, Torcellini CA, Letts RG. The role of intercellular adhesion molecule 1 in chronic airway inflammation. Clin Exp Allergy 1992; 22:569-78.
5. Hemler ME. VLA proteins of the integrin family: structures, functions and their role on leukocytes. Ann Rev Immunol 1990; 8:365.
6. Bevilacqua M, Butcher E, Furie B. Selectins: a family of adhesion receptors. Cell 1991; 67:233.
7. Calderon E, Lockey RF. A possible role for adhesion molecules in asthma. J Allergy Clin Immunology 1992; 90:852.
8. Smith CH, Barker JW, Lee TH. Adhesion molecules in allergic inflammation. Am Rev Resp Dis 1993 :148:s75.
9. Ciprandi G, Buscaglia S, Pesce GP, et al. Allergic subjects express intercellular adhesion molecule 1 on epithelial cells of conjunctiva after specific allergenic challenge. J Allergy Clin Immunol 1993; 91:783.
10. Ciprandi G, Pronzato C, Ricca V, et al. Allergen specific challenge induces ICAM1 expression on nasal epithelial cells in allergic subjects: relationships with early and late phase events. Am Rev Resp Crit Care Med 1994.
11. Bonini S, Bonini S, Vecchione A, et al. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 1988; 82:462-9.
12. Aichane A, Campbell AM, Chanal I, et al. Precision of conjunctival provocation test in right and left eyes. J Allergy Clin Immunol 1993; 92:49-55.
13. Bonini S, Bonini S, Todini V, Adriani E, Allnsmith R. Late phase ocular reaction induced by conjunctival allergen challenge. Allergy Clin Immunol 1988; 81:173-7.
14. Ciprandi G, Buscaglia S, Pesce GP, et al. Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitic patients with allergy due to mites. J Allergy Clin Immunol 1995; 96:971-9.
15. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989; 56:839.
16. 1 Receptor Antagonists in Allergic Disease, Marcel Dekker inc, Basel 1997.
17. Canonica GW, Ciprandi G. Adhesion molecules of allergic inflammation. Recent insights into their functional role. Allergy 1994; 49:135-8.
18. Buscaglia S, Catrullo A, Ciprandi G, et al. Topical ocular Levocabastine reduces ICAM-1 expression both in vitro and in vivo. Clin Exp Allergy 1996; 26:1188-96.
19. Paolieri F, Riccio AM, Battifora M, et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998; 81:601-7.
20. Ciprandi G, Buscaglia S, Catrullo A, et al. Antiallergic activity of azelastine eye drops. Clin Exp Allergy 1996; 26:187-92.
21. Ciprandi G, Pronzato C, Passalacqua G, et al. Topical azelastine reduces eosinophil activation and ICAM-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1997; 98:1088-96.
22. Ciprandi G, Ricca V, Passalacqua G, et al. Seasonal rhinitis and azelastine. Long or short term treatment? J Allergy Clin Immunol 1997; 99:301-7.
23. Ciprandi G, Buscaglia S, Pesce GP, et al. Cetirizine reduces inflammatory cell recruitment and ICAM1 expression on conjunctival epithelium both in early and late phase reaction after specific allergenic challenge. J Allergy Clin Immunol 1995; 95:612-8.
24. Ciprandi G, Tosca MA, Ricca V, et al. Cetirizine treament of rhinitis in children with pollen allergy. Clin Exp Allergy 1997; 27:591-5.
25. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-1 expression on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite allergic asthma. Int Arch Allergy Immunol 1996; 109:272-6.
26. Ciprandi G, Buscaglia S, Pronzato C, et al. Oxatomide reduces inflammatory events induced by allergen specific conjunctival challenge. Ann Allergy Asthma Immunol 1995; 75:446-52.
27. Ciprandi G, Pronzato C, Ricca V, et al. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995; 25:871-8.
28. Ciprandi G, Pronzato C, Ricca V, et al. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 1997; 27:118-23.
29. Ciprandi G, Catrullo A, Cerqueti P, Tosca MA, Canonica GW. Loratadine reduces ICAM-1 expression on conjunctiva after specific challenge in pollen allergic patients. Allergy 1998; 53:545-6.
30. Ciprandi G, Passalacqua G, Ricca V, Tosca MA, Canonica GW. Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79:507-11.